List view / Grid view
7 October 2014 | By Medical Research Council
Three ambitious new research programmes, which aim to deliver a step-change in our understanding of disease by using human volunteers in experimental studies, have been funded as part of a £60m investment from the Medical Research Council...
7 October 2014 | By Embo Medical
Early-stage medical device company is developing minimally invasive embolization technology for the treatment of wide variety of diseases...
6 October 2014 | By GlaxoSmithKline
GlaxoSmithKline plc announced the appointment of Mr Urs Rohner to its Board as a Non-Executive Director, effective 1 January 2015...
6 October 2014 | By Novartis
Novartis announced that it has entered into a clinical collaboration with Bristol-Myers Squibb Company to evaluate the safety, tolerability and preliminary efficacy of three molecularly targeted compounds in combination with Bristol-Myers Squibb's investigational PD-1 immune checkpoint inhibitor...
6 October 2014 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center announced a novel clinical research collaboration to evaluate multiple immunotherapies...
6 October 2014 | By The Ministry of Health
The Ministry of Health has installed a Biosafety Level 3 (BSL-3) mobile lab outside East Arafat Hospital as part of its public-health preparedness program for Hajj...
6 October 2014 | By CleveXel Pharma
They will address the treatment of bone marrow cancers and the diagnosis of patients who are resistant to standard treatments...
3 October 2014 | By OBN
OBN revealed last night the winners of its Annual Awards celebrating the best of UK life sciences – the innovators, fundraisers and dealmakers who underline the pre-eminence of the UK sector in the global marketplace...
3 October 2014 | By Allied-Bristol Life Sciences
Allied-Bristol Life Sciences today announced that Satish Jindal, Ph.D., formerly Vice President of R&D within Bristol-Myers, has been appointed to lead the company’s efforts to identify and foster development of biopharmaceutical innovations from top U.S. university research institutions...
3 October 2014 | By Agar Scientific
Paul joins Agar Scientific from Ronexprim SRL – where he was an Executive Director and the Area Sales Manager for PANalytical X-ray equipment and FEI electronic microscopes in Romanian territories...
2 October 2014 | By Eli Lilly and Company
Eli Lilly and Company announced today it will discontinue development of tabalumab -- being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) -- due to insufficient efficacy in two pivotal Phase 3 trials. The decision was not based on safety concerns. ..
News from the European Pharmacopoeia:
2 October 2014 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company will announce results for the third quarter on Friday, October 24, 2014...
Scientists involved in materials characterization, process validation and product failure analysis can gather more valuable data by combining two powerful analytical techniques. The new Thermo Scientific TGA-IR Module provides users of Thermo Scientific FT-IR spectrometers with enhanced performance when combining Thermal Gravimetric Analysis (TGA) and FT-IR spectroscopy.
1 October 2014 | By Daiichi Sankyo
Daiichi Sankyo Company Limited announced that it and its domestic generic subsidiary, Daiichi Sankyo Espha Co., Ltd. have submitted a supplemental New Drug Application (sNDA) in Japan...
